Upgrade to SI Premium - Free Trial

Insmed (INSM) PT Raised to $195 at Mizuho

August 24, 2026 3:37 PM
Mizuho analyst Graig Suvannavejh raised the price target on Insmed (NASDAQ: INSM) to $195.00 (from $192.00) while maintaining a Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change